Cathepsin K Deficiency Prevented Kidney Damage and Dysfunction in Response to 5/6 Nephrectomy Injury in Mice With or Without Chronic Stress

Background: Chronic psychological stress is a risk factor for kidney disease, including kidney dysfunction and hypertension. Lysosomal CatK (cathepsin K) participates in various human pathobiologies. We investigated the role of CatK in kidney remodeling and hypertension in response to 5/6 nephrectomy injury in mice with or without chronic stress. Methods: Male 7-week-old WT (wild type; CatK+/+) and CatK-deficient (CatK−/−) mice that were or were not subjected to chronic stress underwent 5/6 nephrectomy. At 8 weeks post-stress/surgery, the stress was observed to have accelerated injury-induced glomerulosclerosis, proteinuria, and blood pressure elevation. Results: Compared with the nonstressed mice, the stressed mice showed increased levels of TLR (Toll-like receptor)-2/4, p22phox, gp91phox, CatK, MMP (matrix metalloproteinase)-2/9, collagen type I and III genes, PPAR-γ (peroxisome proliferator-activated receptor-gamma), NLRP-3 (NOD-like receptor thermal protein domain associated protein 3), p21, p16, and cleaved caspase-8 proteins, podocyte foot process effacement, macrophage accumulation, apoptosis, and decreased levels of Bcl-2 (B cell lymphoma 2) and Sirt1, as well as decreased glomerular desmin expression in the kidneys. These harmful changes were retarded by the genetic or pharmacological inhibition of CatK. Consistently, CatK inhibition ameliorated 5/6 nephrectomy–related kidney injury and dysfunction. In mesangial cells, CatK silencing or overexpression, respectively, reduced or increased the PPAR-γ and cleaved caspase-8 protein levels, providing evidence and a mechanistic explanation of CatK’s involvement in PPAR-γ/caspase-8–mediated cell apoptosis in response to superoxide and stressed serum. Conclusions: These results demonstrate that CatK plays an essential role in kidney remodeling and hypertension in response to 5/6 nephrectomy or stress, possibly via a reduction of glomerular inflammation, apoptosis, and fibrosis, suggesting a novel therapeutic strategy for controlling kidney injury in mice under chronic psychological stress conditions.

[1]  Ji Sun Kim,et al.  Psychological distress of patients with end-stage kidney disease undergoing dialysis during the 2019 coronavirus disease pandemic: A cross-sectional study in a University Hospital , 2021, PloS one.

[2]  X. Cheng,et al.  Role of Dipeptidyl Peptidase-4 in Atherosclerotic Cardiovascular Disease in Humans and Animals with Chronic Stress. , 2021, International heart journal.

[3]  Jianzhong Lu,et al.  Calcium-sensing receptor promotes calcium oxalate crystal adhesion and renal injury in Wistar rats by promoting ROS production and subsequent regulation of PS ectropion, OPN, KIM-1, and ERK expression , 2021, Renal failure.

[4]  M. Sims,et al.  Association between goal-striving stress and rapid kidney function decline among African Americans: the Jackson Heart Study , 2020, Journal of Investigative Medicine.

[5]  A. Garg,et al.  Biomarkers of inflammation and repair in kidney disease progression. , 2020, The Journal of clinical investigation.

[6]  G. Metz,et al.  Cardiorenal metabolic biomarkers link early life stress to risk of non-communicable diseases and adverse mental health outcomes , 2020, Scientific Reports.

[7]  Yuting Liu,et al.  ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway , 2020, Cell Death & Disease.

[8]  X. Cheng,et al.  Increased dipeptidyl peptidase-4 accelerates chronic stress-related thrombosis in a mouse carotid artery model. , 2020, Journal of hypertension.

[9]  T. Murohara,et al.  Deficiency of cysteinyl cathepsin K suppresses the development of experimental intimal hyperplasia in response to chronic stress. , 2020, Journal of hypertension.

[10]  K. Okumura,et al.  PLF‐1 (Proliferin‐1) Modulates Smooth Muscle Cell Proliferation and Development of Experimental Intimal Hyperplasia , 2019, Journal of the American Heart Association.

[11]  L. Lanfumey,et al.  Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity , 2019, Nature Medicine.

[12]  P. Libby,et al.  Differential Roles of Cysteinyl Cathepsins in TGF-β Signaling and Tissue Fibrosis , 2019, iScience.

[13]  L. Smeeth,et al.  Cross-sectional study of association between psychosocial stressors with chronic kidney disease among migrant and non-migrant Ghanaians living in Europe and Ghana: the RODAM study , 2019, BMJ Open.

[14]  G. Parati,et al.  Neuroimmune crosstalk in the pathophysiology of hypertension , 2019, Nature Reviews Cardiology.

[15]  T. Murohara,et al.  Cathepsin S Deficiency Mitigated Chronic Stress–Related Neointimal Hyperplasia in Mice , 2019, Journal of the American Heart Association.

[16]  P. Libby,et al.  Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction. , 2019, Journal of molecular and cellular cardiology.

[17]  M. Sims,et al.  Goal-Striving Stress Is Associated with Chronic Kidney Disease Among Participants in the Jackson Heart Study , 2019, Journal of Racial and Ethnic Health Disparities.

[18]  P. Libby,et al.  Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials , 2018, Nature Reviews Cardiology.

[19]  H. Krum,et al.  Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome , 2017, PloS one.

[20]  K. Okumura,et al.  Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia‐Induced Neovascularization: The Role of Dipeptidyl Peptidase‐4/Glucagon‐Like Peptide‐1‐Adiponectin Axis , 2017, Journal of the American Heart Association.

[21]  K. Okumura,et al.  Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress. , 2017, International journal of cardiology.

[22]  K. Okumura,et al.  Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress. , 2017, Atherosclerosis.

[23]  M. Runge,et al.  NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis. , 2017, Journal of molecular and cellular cardiology.

[24]  K. Krause,et al.  NADPH oxidase 4 deficiency increases tubular cell death during acute ischemic reperfusion injury , 2016, Scientific Reports.

[25]  T. Murohara,et al.  Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K−Akt/p-HDAC6 Signaling Pathway , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Johan Kuiper,et al.  Acute and chronic psychological stress as risk factors for cardiovascular disease: Insights gained from epidemiological, clinical and experimental studies , 2015, Brain, Behavior, and Immunity.

[27]  Kumar Sharma,et al.  Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development , 2014, Nature Medicine.

[28]  K. Okumura,et al.  Cathepsin K-mediated notch1 activation contributes to neovascularization in response to hypoxia , 2014, Nature Communications.

[29]  K. Okumura,et al.  Cathepsin K Activity Controls Injury-Related Vascular Repair in Mice , 2014, Hypertension.

[30]  M. Hayashi,et al.  Impact of circulating cathepsin K on the coronary calcification and the clinical outcome in chronic kidney disease patients , 2014, Heart and Vessels.

[31]  Chao-ke Tang,et al.  Psychological stress, immune response, and atherosclerosis. , 2012, Atherosclerosis.

[32]  K. Okumura,et al.  Role for Cysteine Protease Cathepsins in Heart Disease: Focus on Biology and Mechanisms With Clinical Implication , 2012, Circulation.

[33]  K. Okumura,et al.  Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. , 2011, Hypertension.

[34]  K. Okumura,et al.  Angiotensin Type 1 Receptor Blocker Reduces Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice , 2011, Hypertension.

[35]  K. Okumura,et al.  Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatin , 2011, Journal of hypertension.

[36]  Michael C. Ostrowski,et al.  Free Cholesterol Accumulation in Macrophage Membranes Activates Toll-Like Receptors and p38 Mitogen-Activated Protein Kinase and Induces Cathepsin K , 2009, Circulation research.

[37]  F. Dhabhar Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection versus Immunopathology , 2008, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[38]  J. Kiecolt-Glaser,et al.  Stress-induced immune dysfunction: implications for health , 2005, Nature Reviews Immunology.

[39]  B. Kasiske,et al.  Pharmacologic Treatment of Hyperlipidemia Reduces Glomerular Injury in Rat 5/6 Nephrectomy Model of Chronic Renal Failure , 1988, Circulation research.